Roundhill Roundup - We’re So Back (or Are We?)
In early August, equity volatility spiked to levels last seen in 2020, reflecting market jitters...
Second Quarter Earnings Season - What are Companies Talking About?
Roughly 95% of the S&P 500 have reported earnings results for 2Q’24. With a beat rate of roughly...
Why Dividend Monarchs and Why Now
Volatility Spiking as Market Corrects The market is staring down the barrel of multiple headwinds...
Roundhill Roundup - Bye or Buy July
Stocks rallied sharply through the first 8 days with the Magnificent Seven stocks up over 10% and...
Solving China’s Stock Market Diversification Problem
Historically, emerging market equities have earned a spot in investor portfolios under the premise...
High Risk, High Reward for the Magnificent Seven
High Expectations for Earnings Season The Roundhill Magnificent Seven ETF (MAGS) climbed 15.2% in...
In-Network Stocks for OZEM
Originally developed for diabetes treatment, the discovery of GLP-1 therapeutics as a weight loss...
Roundhill Roundup - The “Winner Takes All” Market
With major indexes hitting all-time high after all-time high, you would think investors would be...
A Response to "There Is No Magnificent Seven"
On June 14, 2024, Allan Sloan published a commentary in Barron’s with the headline “There Is No...
Roundhill Roundup: Markets Go Up
Last year, a knock on the market was its lack of breadth, whereby a small number of names were...
Digging Deeper: Return of Capital Distributions in ETFs
In our previous blog we discussed the basics of ETF distributions, including how amounts are...
How to Invest in Weight Loss Drugs: The Complete Beginners Guide
A recent report from the Centers for Disease Control and Prevention (CDC) at the end of 2023...
Introducing OZEM: The GLP-1 Skinny
Addressing the Obesity Epidemic The global obesity epidemic has reached alarming proportions. Since...
Behind the Curtain: ETF Distributions
Most ETFs are structured as Regulated Investment Companies, commonly referred to as RICs. As RICs,...
What are 0DTE Options? Demystifying Zero-Days-To-Expiry
Zero-days-to-expiry options, or “0DTE” options, have become a popular topic of discussion amongst...